Company Claim
Is this your company?
Claiming your profile lets you keep your information accurate, control what's visible, and see how buyers are finding you on Fundup AI.
ErVimmune
Biotechnology company developing next-generation therapeutic vaccines and cell therapies targeting 'cold tumors' using human endogenous retroviruses (HERVs) as tumor antigens, with lead candidate ErVac01 for triple-negative breast cancer and ovarian cancer.
What you get after claiming
Edit your profile
Update your logo, description, website, and industry
Control visibility
Choose what appears publicly on your profile page
Verified badge
Build trust with buyers who find you through funding intel
Correct inaccurate data
Request changes to funding records and company details
How it works
-
1
Sign in or create a free account
No credit card required
-
2
Verify with your work email
Your email must match the company domain to confirm ownership
-
3
Manage your profile
Edit details, control visibility, and keep your data accurate
Ready to claim ErVimmune?
Sign in with your work email to begin verification. Free, no credit card needed.
Not affiliated with this company? Browse the funding feed instead.